↓ Skip to main content

Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer

Overview of attention for article published in Frontiers in oncology, August 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer
Published in
Frontiers in oncology, August 2020
DOI 10.3389/fonc.2020.01245
Pubmed ID
Authors

Lijuan Lyu, Jia Yao, Meng Wang, Yi Zheng, Peng Xu, Shuqian Wang, Dai Zhang, Yujiao Deng, Ying Wu, Si Yang, Jun Lyu, Feng Guan, Zhijun Dai

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 17%
Student > Bachelor 4 17%
Researcher 3 13%
Student > Ph. D. Student 1 4%
Other 1 4%
Other 0 0%
Unknown 11 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 33%
Medicine and Dentistry 4 17%
Agricultural and Biological Sciences 1 4%
Unknown 11 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2020.
All research outputs
#17,054,888
of 25,838,141 outputs
Outputs from Frontiers in oncology
#6,769
of 22,812 outputs
Outputs of similar age
#262,275
of 428,179 outputs
Outputs of similar age from Frontiers in oncology
#193
of 567 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,812 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,179 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 567 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.